Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
11.44
-0.03 (-0.26%)
Apr 29, 2025, 10:18 AM EDT - Market open

Nurix Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Dec - Nov.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Apr '25 Nov '24 Nov '23 Nov '22 Nov '21 Nov '20 2018 - 2019
Market Capitalization
8721,5663025841,2861,656
Upgrade
Market Cap Growth
94.16%419.13%-48.35%-54.57%-22.36%-
Upgrade
Enterprise Value
3491,136411849421,302
Upgrade
Last Close Price
11.4722.116.2212.3928.8242.62
Upgrade
PS Ratio
15.1028.713.9215.1243.2292.93
Upgrade
PB Ratio
1.822.971.511.923.765.71
Upgrade
P/TBV Ratio
1.812.971.511.923.765.71
Upgrade
EV/Sales Ratio
6.1920.820.534.7631.6673.05
Upgrade
Debt / Equity Ratio
0.060.050.150.040.04-
Upgrade
Asset Turnover
0.120.110.200.090.070.08
Upgrade
Quick Ratio
6.136.383.324.394.576.58
Upgrade
Current Ratio
6.266.463.404.514.706.70
Upgrade
Return on Equity (ROE)
-64.16%-53.22%-57.10%-55.84%-37.05%-30.80%
Upgrade
Return on Assets (ROA)
-31.08%-25.98%-25.10%-25.72%-16.88%-18.45%
Upgrade
Return on Capital (ROIC)
-40.87%-33.86%-35.45%-34.25%-22.82%-28.93%
Upgrade
Earnings Yield
-23.90%-12.36%-47.71%-30.88%-9.12%-2.61%
Upgrade
FCF Yield
-23.11%-11.61%-29.75%-29.45%-7.00%-0.28%
Upgrade
Buyback Yield / Dilution
-36.16%-23.52%-11.79%-13.32%-173.68%-376.03%
Upgrade
Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q